This site uses cookies to give you a better browsing experience. By continuing to use this website, you accept our use of these cookies. For more information, see our Privacy and Cookie Notice.

Skip to main content
alt text

Brendan O'Grady

Executive Vice President, North America Commercial

Brendan O’Grady became Executive Vice President, North America Commercial in November 2017.

From 2016 until November 2017, he served as Chief Commercial Officer, Global Specialty Medicines and served as interim head of Teva’s European Specialty business. Prior to that, he held various senior roles since joining Teva in 2011 as Regional Account Manager, and from 2015 to 2016, he served as President and CEO, Teva North America Generics.

Prior to joining Teva, Mr. O’Grady spent ten years with Sanofi predecessor companies in a variety of commercial and medical affairs roles that began in field sales.

He received his B.S. from Geneseo State University, NY in management science/marketing and holds an M.B.A. from Baker University in Baldwinsville, Kansas.


Annamaria Lesch

Kåre Schultz

President & CEO

Read more
Annamaria Lesch

Richard Daniell

Executive Vice President, European Commercial

Read more
Annamaria Lesch

Dr. Sven Dethlefs

Executive Vice President, Global Marketing & Portfolio

Read more
Annamaria Lesch

Eric Drapé

Executive Vice President, Global Operations

Read more
Annamaria Lesch

Dr. Hafrun Fridriksdottir

Executive Vice President, Global R&D

Read more
Annamaria Lesch

Gianfranco Nazzi

Executive Vice President, International Markets Commercial

Read more
Annamaria Lesch

Eli Kalif

Executive Vice President and Chief Financial Officer (CFO)

Read more
Annamaria Lesch

Mark Sabag

EVP, Chief Human Resources Officer and Global Communications & Brand

Read more
Annamaria Lesch

David M. Stark

Executive Vice President, Chief Legal Officer

Read more
Annamaria Lesch

Nir Baron

Senior Vice President, Chief Internal Auditor

Read more
Annamaria Lesch

Lori Queisser

Sr. Vice President & Global Compliance Officer

Read more